Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jihane Faress MD is a Staff Member in the Department of Pulmonary, Allergy and Critical Care Medicine. She is also Assistant Professor of Medicine at Cleveland Clinic’s Lerner College of Medicine.
She obtained her medical degree from the St. Joseph University School of Medicine in Beirut, Lebanon, where she also completed an internship. From 2000-2003, she completed a residency in internal medicine at East Tennessee State University in Johnson City, Tennessee. From 2003-2006, Dr. Faress completed fellowship in pulmonary & critical care medicine (followed by a year of advanced fellowship/research fellowship (2006-2007) at UH-Case Medical Center. In 2007, she was appointed on the faculty of Case Medical Center, with clinical activities at the VA and University Hospitals where she ran a busy Interstitial Lung Diseases Clinic and also served as the Associate Program Director of the Pulmonary and Critical Care fellowship.
In January 2013, she joined the Cleveland Clinic Respiratory Institute to be part of the Interstitial Lung Diseases Program. Her clinical practice is composed of complex patients with interstitial lung diseases and Sarcoidosis. She is also an active member of the critical care team and attends in the Medical ICU.
Specialty interests are Interstitial Lung Diseases, IPF, Hypersensitivity pneumonitis, Sarcoidosis, Alveolar proteinosis, Langerhans cell histiocytosis (LCH), lymphangioleiomyomatosis (LAM), eosinophilic lung diseases, cryptogenic oprganizing pneumonia.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/18/2014, Dr. Faress has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.